Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/113759
Citations | ||
Scopus | Web of Science® | Altmetric |
---|---|---|
?
|
?
|
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Liu, G. | - |
dc.contributor.author | Tu, D. | - |
dc.contributor.author | Lewis, M. | - |
dc.contributor.author | Cheng, D. | - |
dc.contributor.author | Sullivan, L. | - |
dc.contributor.author | Chen, Z. | - |
dc.contributor.author | Morgen, E. | - |
dc.contributor.author | Simes, J. | - |
dc.contributor.author | Price, T. | - |
dc.contributor.author | Tebbutt, N. | - |
dc.contributor.author | Shapiro, J. | - |
dc.contributor.author | Jeffery, G. | - |
dc.contributor.author | Mellor, J. | - |
dc.contributor.author | Mikeska, T. | - |
dc.contributor.author | Virk, S. | - |
dc.contributor.author | Shepherd, L. | - |
dc.contributor.author | Jonker, D. | - |
dc.contributor.author | O'Callaghan, C. | - |
dc.contributor.author | Zalcberg, J. | - |
dc.contributor.author | Karapetis, C. | - |
dc.contributor.author | et al. | - |
dc.date.issued | 2016 | - |
dc.identifier.citation | Clinical Cancer Research, 2016; 22(10):2435-2444 | - |
dc.identifier.issn | 1078-0432 | - |
dc.identifier.issn | 1557-3265 | - |
dc.identifier.uri | http://hdl.handle.net/2440/113759 | - |
dc.description.abstract | Abstract not available | - |
dc.description.statementofresponsibility | Geoffrey Liu, Dongsheng Tu, Marcia Lewis, Dangxiao Cheng, Leslie A. Sullivan, Zhuo Chen, Eric Morgen, John Simes, Timothy J. Price, Niall C. Tebbutt, Jeremy D. Shapiro, G. Mark Jeffery, J. Daniel Mellor, Thomas Mikeska, Shakeel Virk, Lois E. Shepherd, Derek J. Jonker, Christopher J. O'Callaghan, John R. Zalcberg, Christos S. Karapetis, and Alexander Dobrovic | - |
dc.language.iso | en | - |
dc.publisher | American Association for Cancer Research | - |
dc.rights | ©2016 American Association for Cancer Research. | - |
dc.source.uri | http://dx.doi.org/10.1158/1078-0432.ccr-15-0414 | - |
dc.subject | Cetuximab therapy | - |
dc.title | Fc-γ receptor polymorphisms, cetuximab therapy, and survival in the NCIC CTG CO.17 trial of colorectal cancer | - |
dc.title.alternative | Fc-gamma receptor polymorphisms, cetuximab therapy, and survival in the NCIC CTG CO.17 trial of colorectal cancer | - |
dc.type | Journal article | - |
dc.identifier.doi | 10.1158/1078-0432.CCR-15-0414 | - |
pubs.publication-status | Published | - |
dc.identifier.orcid | Price, T. [0000-0002-3922-2693] | - |
Appears in Collections: | Aurora harvest 3 Medicine publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.